Implication of circulating memory B cells in late-onset myasthenia gravis

Hiroyuki Murai

doi:10.1111/cen3.12222

Implication of circulating memory B cells in late-onset myasthenia gravis

Hiroyuki Murai

Faculty of Medical Sciences

Research output: Contribution to journal › Short survey

Abstract

Abstract Myasthenia gravis is a heterogeneous disease, and it presents various clinical differences according to the age of onset. Immunological backgrounds that cause these differences are not well understood. Kubota et al. investigated subsets of circulating T and B lymphocytes using various markers. They argued that a reduced percentage of memory B cells seems to be a characteristic of late-onset myasthenia gravis.

Original language	English
Pages (from-to)	220-221
Number of pages	2
Journal	Clinical and Experimental Neuroimmunology
Volume	6
Issue number	3
DOIs	https://doi.org/10.1111/cen3.12222
Publication status	Published - Aug 1 2015

All Science Journal Classification (ASJC) codes

Neuroscience (miscellaneous)
Immunology
Immunology and Microbiology (miscellaneous)
Clinical Neurology

Access to Document

10.1111/cen3.12222

Fingerprint Dive into the research topics of 'Implication of circulating memory B cells in late-onset myasthenia gravis'. Together they form a unique fingerprint.

Cite this

Murai, H. (2015). Implication of circulating memory B cells in late-onset myasthenia gravis. Clinical and Experimental Neuroimmunology, 6(3), 220-221. https://doi.org/10.1111/cen3.12222

@article{3573fba6daa444d788165cff50b0a146,

title = "Implication of circulating memory B cells in late-onset myasthenia gravis",

abstract = "Abstract Myasthenia gravis is a heterogeneous disease, and it presents various clinical differences according to the age of onset. Immunological backgrounds that cause these differences are not well understood. Kubota et al. investigated subsets of circulating T and B lymphocytes using various markers. They argued that a reduced percentage of memory B cells seems to be a characteristic of late-onset myasthenia gravis.",

author = "Hiroyuki Murai",

year = "2015",

month = aug,

day = "1",

doi = "10.1111/cen3.12222",

language = "English",

volume = "6",

pages = "220--221",

journal = "Clinical and Experimental Neuroimmunology",

issn = "1759-1961",

publisher = "John Wiley and Sons Ltd",

number = "3",

}

TY - JOUR

T1 - Implication of circulating memory B cells in late-onset myasthenia gravis

AU - Murai, Hiroyuki

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Abstract Myasthenia gravis is a heterogeneous disease, and it presents various clinical differences according to the age of onset. Immunological backgrounds that cause these differences are not well understood. Kubota et al. investigated subsets of circulating T and B lymphocytes using various markers. They argued that a reduced percentage of memory B cells seems to be a characteristic of late-onset myasthenia gravis.

AB - Abstract Myasthenia gravis is a heterogeneous disease, and it presents various clinical differences according to the age of onset. Immunological backgrounds that cause these differences are not well understood. Kubota et al. investigated subsets of circulating T and B lymphocytes using various markers. They argued that a reduced percentage of memory B cells seems to be a characteristic of late-onset myasthenia gravis.

UR - http://www.scopus.com/inward/record.url?scp=84938370527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938370527&partnerID=8YFLogxK

U2 - 10.1111/cen3.12222

DO - 10.1111/cen3.12222

M3 - Short survey

AN - SCOPUS:84938370527

VL - 6

SP - 220

EP - 221

JO - Clinical and Experimental Neuroimmunology

JF - Clinical and Experimental Neuroimmunology

SN - 1759-1961

IS - 3

ER -